Delivery Order SPE2DB22D1106-SPE2DB24FDJY7
Award Date
10/27/23
Potential Completion Date
10/30/23
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,097.08, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has an ultimate completion date of March 8, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp is a major...
This federal contract award, valued at $5,080.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of October 19, 2023 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $3,345.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a medical product. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., the parent company. This contract is a delivery order, with a firm fixed-price pricing type and an...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $1,834.55. The contract is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. This award is part of the larger $999,999,999 IDC held by Cencora, Inc. with the DLA, which serves as the primary vehicle for the company to deliver a comprehensive...
This federal contract award, valued at $1,527.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 28, 2023. This award is not associated with a set-aside designation, indicating it was awarded through full and open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,003.82 firm fixed-price delivery order is for the supply of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 14, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government agencies, particularly the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of WEGOVY 1 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,387.34 and a performance period ending on January 30, 2024. The contract is a Firm Fixed Price Delivery Order, and no set-aside designation was used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., to provide WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a total potential value of $1,074.54 and a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside was used for this award. This delivery order is part of a larger indefinite delivery contract (IDC) with...
This federal contract award, valued at $1,532.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of WEGOVY 0.5 mg/0.5 ml pens, a pharmaceutical product, to support DLA's medical supply requirements. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,172.14 firm fixed-price delivery order is for WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...